Health care costs

Health care costs

Comparative Efficacy and Cost-Effectiveness of Tenofovir Amibufenamide, Tenofovir Alafenamide, and Centralized Volume-Based Procurement Tenofovir Alafenamide in Chronic Hepatitis B Treatment

A recent study published in the journal Current Medical Science has shed light on the comparative efficacy and cost-effectiveness of three regimens used to treat chronic hepatitis B (CHB): tenofovir amibufenamide (TMF), tenofovir alafenamide (TAF), and centralized volume-based procurement (CVBP) TAF. The study, conducted at Tianjin University Central Hospital, analyzed